Login / Signup
Katja A Oppelt
ORCID
Publication Activity (10 Years)
Years Active: 2021-2021
Publications (10 Years): 1
Top Topics
Prognostic Factors
Adverse Drug
Health Insurance
Advanced Non Small Cell Lung Cancer
Top Venues
Future oncology (London, England)
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Sarina Schwarz
,
Katja A Oppelt
,
Miriam Heinig
,
Ulrike Haug
Potential of German claims data to characterize utilization of new cancer drugs: the example of crizotinib.
Future oncology (London, England)
17 (18) (2021)